Pilot Study of Exposure Therapy for Posttraumatic Stress Disorder
1 other identifier
interventional
14
1 country
1
Brief Summary
The purpose of this project is to examine the feasibility of a culturally adapted, manual based Prolonged Exposure therapy intervention for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Nov 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 28, 2011
CompletedFirst Posted
Study publicly available on registry
March 1, 2011
CompletedMarch 1, 2011
February 1, 2011
1.3 years
February 28, 2011
February 28, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinician-Administered PTSD Scale
The Clinician-Administered PTSD Scale is a semi-structured interview designed to assess posttraumatic stress disorder (PTSD) diagnostic status and symptom severity.
Baseline, week 8, week 16
Study Arms (2)
Prolonged Exposure
EXPERIMENTALUsual care
ACTIVE COMPARATORInterventions
15 psychotherapy sessions focused on helping clients overcome avoidance behaviors and emotionally process trauma-related memories
Per usual care, patients are referred to a mental health provider within the health care setting.
Eligibility Criteria
You may qualify if:
- diagnosis of PTSD
- CAPS score of at least 45
- to 65 years old
- Spanish speaker
- competent to provide informed consent
You may not qualify if:
- history of bipolar disease, schizophrenia or psychotic disorder
- alcohol or drug abuse in the past three months
- moderate to severe traumatic brain injury
- applying for or receiving disability benefits
- clinically judged to have a high acute suicide risk
- life-threatening medical condition
- currently receiving psychotherapy for PTSD or changed psychotropic medication within 2 months of randomization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Puerto Rico, Medical Sciences Campus
San Juan, 00936, Puerto Rico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 28, 2011
First Posted
March 1, 2011
Study Start
November 1, 2008
Primary Completion
March 1, 2010
Study Completion
October 1, 2010
Last Updated
March 1, 2011
Record last verified: 2011-02